Prognostic factors of overall and prostate-specific antigen-progression-free survival in metastatic castration-resistant prostate cancer patients treated with Lu-177-PSMA-617. A single-center prospective observational study

---

Telli T., Tuncel M., Karabulut E., Aksoy S., Erman M., Akdogan B., ...Daha Fazla

PROSTATE, cilt.83, sa.8, ss.792-800, 2023 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 83 Sayı: 8
• Basım Tarihi: 2023
• Dergi Adı: PROSTATE
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, EMBASE, Gender Studies Database, MEDLINE, Veterinary Science Database
• Sayfa Sayıları: ss.792-800
• Anahtar Kelimeler: Lu-177-PSMA-617, Ga-68-PSMA, FDG PET-CT, metastatic castration-resistant prostate carcinoma, prognostic factors, survival
• Hacettepe Üniversitesi Adresli: Evet